# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-14-004769
Filing Date
2014-08-13
Accepted
2014-08-12 20:34:54
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | form10q.htm | 10-Q | 266001
2 | EXHIBIT 31.1 | exhibit31-1.htm | EX-31.1 | 4410
3 | EXHIBIT 32.1 | exhibit32-1.htm | EX-32.1 | 3178
| Complete submission text file | 0001062993-14-004769.txt |  | 5056457

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | avxl-20140630.xml | EX-101.INS | 344556
5 | XBRL SCHEMA FILE | avxl-20140630.xsd | EX-101.SCH | 178086
6 | XBRL CALCULATION FILE | avxl-20140630_cal.xml | EX-101.CAL | 44319
7 | XBRL DEFINITION FILE | avxl-20140630_def.xml | EX-101.DEF | 489864
8 | XBRL LABEL FILE | avxl-20140630_lab.xml | EX-101.LAB | 1157691
9 | XBRL PRESENTATION FILE | avxl-20140630_pre.xml | EX-101.PRE | 538406

Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-51652 | Film No.: 141035546
SIC: 8731 Services-Commercial Physical & Biological Research